Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0756
D

Delayed Response to Pharmacist Recommendations on Medication Orders

Philadelphia, Pennsylvania Survey Completed on 07-31-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to act upon irregularities identified by the consulting pharmacist in a timely manner for four residents. According to the facility's policy, pharmacist recommendations must be implemented within seven days. For multiple residents, pharmacy reviews repeatedly noted issues such as missing order durations for PRN psychoactive medications, lack of documented rationale for continued use beyond 14 days, and missing indications for PRN pain medications. These recommendations were documented over several months but were not addressed within the required timeframe. Specifically, one resident with anxiety had pharmacy recommendations regarding the duration and documentation for Clonazepam orders that were not addressed for nearly three months. Another resident with pain management needs had repeated recommendations to clarify PRN pain medication orders for moderate pain, which were not acted upon over a four-month period. Additional residents with orders for Lorazepam, Doxazosin, Valproic Acid, and Alprazolam also had pharmacy-identified irregularities, such as missing order durations and diagnoses, that were not corrected until weeks or months after the initial recommendations. These delays in addressing pharmacist recommendations were confirmed through review of clinical records, pharmacy reviews, and facility policy.

An unhandled error has occurred. Reload 🗙